Search

everythinglearnresearchcommunity

for

Search:↓

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Hair can be used to measure cancer-related chemicals noninvasively.

Certain skin cells near the base of hair muscles may help renew and stabilize skin, possibly affecting skin disorder understanding.

LGR5 is a marker found in hair follicle stem cells in various species and is important for hair growth and skin repair.

Tongue cancer cells show more plectin-1 than non-cancer cells, but both have similar levels of trichohyalin.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

The document lists research on Pemetrexed and Cisplatin for lung cancer but doesn't give a final conclusion.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Men with testicular cancer were less likely to experience baldness and severe acne.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.